Email: rsulldds@aol.com
Richard Sullivan, DDS began a career within Nobel Biocare in 1990, with a relocation to Gothenburg Sweden in 1992 for two years when this was the Nobel Biocare global headquarters. His responsibilities included clinical and laboratory products for North America. This position offered opportunities for product development including three patents, as co-author of four textbook chapters and twenty publications including digital treatment delivery and treating the edentulous arch. He also maintained a part-time private practice throughout this time providing implant placement and restoration. Rick retired from Nobel Biocare after 30 years, and is currently a consultant with Nobel Biocare and the Nevada State Board of Dentistry.
Topic
Preventing implant complications for the edentulous arch
Presentation Synopsis
Optimizing Long-term Restorative Success for the Edentulous Arch
Description
With a 15 year foundation of clinical and radiographic observation of 2,895 implants on consecutive patients, six factors were published in 1981 as “Requirements for Long-Lasting Bone-to implant Anchorage”. For the Brånemark group in Gothenburg Sweden, this clinical research data was based primarily on treatment of the already edentulous jaw with a two stage surgical approach. This edentulous arch experience was supplemented by applications for bone anchored hearing aids, craniofacial prosthesis anchorage, finger joint replacement and other orthopedic reconstruction; still, minimal single tooth or short span dental implant information could be extrapolated until several years later.
Within the edentulous arch implant indication for fixed restoration there have been extensive developments in
There have also been introductions of biological variables
Looked at collectively these new developments since 1981 are all expansions of this original research foundation for the edentulous arch. What has been the impact? The objective of this program will be to review selected clinically relevant developments based on potential patient benefits, clinical performance, return-on-investment, time saved and esthetic advantages.
Learning Objectives
Time
November 30th, 2022
6:30 PM ET to 8:30 PM ET (2 hours)
6:00 PM PT to 8:00 PM PT (2 hours)
CE Credits Offered for this Session: 2